Treatment of localized renal cell carcinoma

被引:0
|
作者
Brinkmann, Isabel [1 ]
Stief, Christian G. [1 ]
Marcon, Julian [1 ]
机构
[1] LMU Klinikum, Urol Klin & Poliklin, Marchioninistr 15, D-81377 Munich, Germany
来源
UROLOGIE | 2024年
关键词
Renal cell carcinoma; Nephrectomy; Ablative therapy; Neoplasia of the kidney; Therapy strategy; INVASIVE PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; SURGICAL-MANAGEMENT; TUMORS; CRYOABLATION; SURVEILLANCE; RADIOTHERAPY; PROGRESSION; PREDICTORS; ABLATION;
D O I
10.1007/s00120-023-02272-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both partial nephrectomy (pNx) and total nephrectomy (TNx) are the mainstay of the surgical treatment of renal cell carcinoma. In smaller masses, ablative treatment as well as surveillance are possible options. Objective: The aim of this article is to provide a closer look at the surgical methods, active surveillance and ablative options as well as the current evidence to support their use. Material and methods: This study is based on a selective literature review regarding pNx and TNx for renal cell carcinoma using the PubMed database and the review of current European and American guidelines on surgical treatment and conservative options for renal cell carcinoma. Results: The choice of surgical method depends on the intrarenal tumor configuration as well as patient comorbidities. While pNx is used for smaller localized masses TNx is usually performed in larger more complex tumors. Both methods can be performed using a minimally invasive (laparoscopic or robotically assisted) or an open approach. In patients with severe comorbidities or a limited life expectancy, local ablative treatment options as well as surveillance strategies are suitable strategies.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 50 条
  • [21] Optimal Management of Localized Renal Cell Carcinoma: Surgery, Ablation, or Active Surveillance
    Chen, David Y. T.
    Uzzo, Robert G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (06): : 635 - 643
  • [22] Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?
    Leopold, Zev
    Passarelli, Rachel
    Mikhail, Mark
    Tabakin, Alexandra
    Chua, Kevin
    Ennis, Ronald D.
    Nosher, John
    Singer, Eric A.
    JOURNAL OF KIDNEY CANCER AND VHL, 2022, 9 (03): : 5 - 23
  • [23] Time to Recurrence after Nephrectomy as a Predictor of Cancer-Specific Survival in Localized Clear-Cell Renal Cell Carcinoma
    Rodriguez-Covarrubias, Francisco
    Olivia Gomez-Alvarado, M.
    Sotomayor, Mariano
    Castillejos-Molina, Ricardo
    Mendez-Probst, Carlos E.
    Gabilondo, Fernando
    Feria-Bernal, Guillermo
    UROLOGIA INTERNATIONALIS, 2011, 86 (01) : 47 - 52
  • [24] Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma
    Midenberg, Eric
    Higgins, Michelle I.
    Schmeusser, Benjamin N.
    Patil, Dattatraya H.
    Zaldumbide, Joel
    Martini, Dylan J.
    Steele, Sean
    Williams, Milton
    Nabavizadeh, Reza
    Psutka, Sarah P.
    Ogan, Kenneth
    Bilen, Mehmet Asim
    Master, Viraj A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 50.e19 - 50.e26
  • [25] RENAL nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
    Nagahara, Akira
    Uemura, Motohide
    Kawashima, Atsunari
    Ujike, Takeshi
    Fujita, Kazutoshi
    Miyagawa, Yasushi
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 367 - 372
  • [26] Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older
    Suk-ouichai, Chalairat
    Patel, Hiten D.
    Sato, Kent T.
    Kundu, Shilajit D.
    Ross, Ashley E.
    Perry, Kent T.
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [27] Sarcomatoid renal cell carcinoma: Biology and treatment advances
    El Mouallem, Nemer
    Smith, Steven C.
    Paul, Asit K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 265 - 271
  • [28] SEOM clinical guidelines for the treatment of renal cell carcinoma
    Bellmunt, J.
    Puente, J.
    Garcia de Muro, J.
    Lainez, N.
    Rodriguez, C.
    Duran, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12) : 1043 - 1050
  • [29] Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
    Ruhle, Alexander
    Andratschke, Nicolaus
    Siva, Shankar
    Guckenberger, Matthias
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 18 : 104 - 112
  • [30] Update on contemporary management of clinically localized renal cell carcinoma
    Jorns, J. J.
    Thiel, D. D.
    Castle, E. P.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 261 - 272